Investing

Cue Biopharma : CUE

CUE

Stock Data

$24.53

$2.56 (9.45%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biological drugs for the selective modulation of the human immune system to treat a variety of cancers, chronic infectious diseases, and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts.

All Cue Biopharma Articles

1 Article

Michael Williams | Apr 13, 2026 at 10:16 AM EDT

The VIX Sharply Reverses and Points Back Towards 30 After Failed Peace Negotiations

The CBOE Volatility Index (VIX) is reversing sharply this Monday morning, spiking more than 7% after weekend negotiations between the…